Immunocore Holdings plc (FRA:6YG)
Germany flag Germany · Delayed Price · Currency is EUR
27.20
-0.20 (-0.73%)
At close: Jan 30, 2026

Immunocore Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-29.23-51.09-55.29-52.54-180.03-101.16
Depreciation & Amortization
3.64.24.095.347.5912.25
Loss (Gain) From Sale of Investments
-16.29-14.58----
Stock-Based Compensation
38.0334.1932.4732.8948.8911.14
Other Operating Activities
2.338.215.89-10.722.433.52
Change in Accounts Receivable
-10.63-12.35-17.87-26.26-4.86-0.73
Change in Accounts Payable
2.017.272.634.911.47-5.15
Change in Unearned Revenue
-0.24-0-8.01-25.5-29.07-33.45
Change in Other Net Operating Assets
18.4150.2129.0422.6910.5-0.06
Operating Cash Flow
7.9926.062.94-49.21-143.11-83.62
Operating Cash Flow Growth
-64.13%786.43%----
Capital Expenditures
-5.04-5.17-5.43-2.2-1.39-4.2
Sale of Property, Plant & Equipment
0.040.04-0.010.110.92
Investment in Securities
-14-350----
Other Investing Activities
-----4.84
Investing Cash Flow
-19-355.13-5.43-2.2-1.281.56
Long-Term Debt Issued
-402.5-50-51.26
Long-Term Debt Repaid
--52.06--52--6.04
Net Debt Issued (Repaid)
-52.06350.44--2-45.21
Issuance of Common Stock
8.646.834.35149.21288.19113.72
Other Financing Activities
--13.36--1.77--0.64
Financing Cash Flow
-43.42343.8834.35145.44288.19158.29
Foreign Exchange Rate Adjustments
15.08-1.718.29-12.650.63-0.11
Net Cash Flow
-39.3513.1140.1581.39144.4276.12
Free Cash Flow
2.9520.89-2.49-51.41-144.49-87.82
Free Cash Flow Margin
0.78%6.73%-1.00%-29.49%-396.04%-213.60%
Free Cash Flow Per Share
0.060.42-0.05-1.13-3.40-3.31
Cash Interest Paid
1.35----0.4
Cash Income Tax Paid
3.740.510.980.77-17.04-55.02
Levered Free Cash Flow
-64.7738.3914.06-19.73-50.31-36.52
Unlevered Free Cash Flow
-54.6850.1717.28-16.35-46.83-33.87
Change in Working Capital
9.5545.135.78-24.17-21.96-39.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.